|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.032 SEK | 0.00% |
|
+3.90% | -90.93% |
| 05-31 | Diagonal Bio AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 05-23 | Diagonal Bio AB Appoints Fata Mrsic as Chief Financial Officer, Effective June 14, 2024 | CI |
Diagonal Bio AB (publ) has appointed Fata Mrsic as the new Chief Financial Officer (CFO). Fata will assume the position on June 14, 2024, and be part of the Management Team. Fata Mrsic has extensive financial and accounting experience.
She has held Business Controller and Accounting positions at several companies in the past 15 years, some with global presence. Fata has a Diploma in Business Controlling from the University of Lund.
| 1st Jan change | Capi. | |
|---|---|---|
| -90.93% | 1.22M | |
| +40.80% | 53.67B | |
| +35.79% | 38.86B | |
| -8.05% | 38.76B | |
| -8.98% | 27.27B | |
| +10.69% | 25.91B | |
| -16.21% | 20.29B | |
| +31.00% | 12.78B | |
| +28.51% | 12.18B | |
| -1.67% | 11.96B |
DIAGONAL BIO AB 
